SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-15-003401
Filing Date
2015-05-08
Accepted
2015-05-08 16:06:17
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0315_actiniumpharma.htm 10-Q 523957
2 AGREEMENT f10q0315ex10i_actinium.htm EX-10.1 23921
3 CERTIFICATION f10q0315ex31i_actinium.htm EX-31.1 14479
4 CERTIFICATION f10q0315ex32i_actinium.htm EX-32.1 7656
  Complete submission text file 0001213900-15-003401.txt   4565462

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE atnm-20150331.xml EX-101.INS 540217
6 XBRL SCHEMA FILE atnm-20150331.xsd EX-101.SCH 46668
7 XBRL CALCULATION FILE atnm-20150331_cal.xml EX-101.CAL 22706
8 XBRL DEFINITION FILE atnm-20150331_def.xml EX-101.DEF 154006
9 XBRL LABEL FILE atnm-20150331_lab.xml EX-101.LAB 399417
10 XBRL PRESENTATION FILE atnm-20150331_pre.xml EX-101.PRE 257233
Mailing Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36374 | Film No.: 15846714
SIC: 2834 Pharmaceutical Preparations